Previous Close | 1.2000 |
Open | 1.2000 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 12.50 |
Expire Date | 2024-12-20 |
Day's Range | 1.2000 - 1.2000 |
Contract Range | N/A |
Volume | |
Open Interest | N/A |
As U.S. markets exhibit resilience with stocks on the rise and the dollar weakening, investors are closely monitoring upcoming inflation data which could influence future monetary policy decisions. In this context, growth companies with high insider ownership stand out as potentially robust investment opportunities, given that high insider stakes often signal confidence in the company's future from those who know it best.
Exploring ARS Pharmaceuticals' Latest Financial Performance and Strategic Milestones
ARS Pharmaceuticals ( NASDAQ:SPRY ) First Quarter 2024 Results Key Financial Results Net loss: US$10.3m (loss narrowed...